文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

重症监护病房患者造影后急性肾损伤:倾向评分校正研究

Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study.
PubMed 文献 · Intensive Care Med · 2017-02-17
一句话结论在CT前eGFR>45的ICU患者中,静脉注射碘造影剂与AKI、急诊透析和短期死亡率风险增加无关;eGFR≤45者透析风险增加。

本研究纳入2006年1月至2014年12月期间在本机构接受增强CT(造影组)或平扫CT(非造影组)的所有ICU患者共6877例(造影组4351例,非造影组2526例),按CT前eGFR>45和≤45分层后分别进行倾向评分分析,比较KDIGO定义的AKI、透析和死亡率。倾向评分校正后,eGFR>45匹配亚组中造影组与非造影组的AKI(31% vs 34%,OR 0.88,95%CI 0.75-1.05,p=0.15)、透析(2.0% vs 1.7%,OR 1.20,95%CI 0.66-2.17,p=0.55)和死亡率(12% vs 14%,OR 0.87,95%CI 0.69-1.10,p=0.23)均无显著差异。eGFR≤45匹配亚组中造影组透析率显著更高(6.7% vs 2.5%,OR 2.72,95%CI 1.14-6.46,p=0.0240)。

要点

  • CT前eGFR>45的ICU患者中,静脉碘造影剂未增加AKI风险(31% vs 34%,OR 0.88,95%CI 0.75-1.05,p=0.15)。
  • CT前eGFR>45者造影后透析率2.0% vs 非造影1.7%(OR 1.20,95%CI 0.66-2.17,p=0.55),无显著差异。
  • CT前eGFR>45者短期死亡率12% vs 14%(OR 0.87,95%CI 0.69-1.10,p=0.23),无显著差异。
  • CT前eGFR≤45匹配亚组中,造影组透析率6.7% vs 非造影组2.5%(OR 2.72,95%CI 1.14-6.46,p=0.0240),造影组显著更高。
  • 研究另对eGFR≥60、30-59和<30亚组分别进行了分析。

适用人群与场景

  • 本机构2006年1月至2014年12月期间接受增强CT(造影组)或平扫CT(非造影组)的所有ICU患者。
  • 按CT前eGFR>45和eGFR≤45分为两个亚组,分别进行倾向评分分析;另对eGFR≥60、30-59和<30亚组分别分析。

诊断标准与关键阈值

  • AKI采用KDIGO定义。

研究设计与关键结果

  • 研究类型为倾向评分校正的队列研究,共纳入6877例ICU患者(造影组4351例,非造影组2526例)。
  • eGFR>45匹配亚组:AKI发生率造影组31% vs 非造影组34%(OR 0.88,95%CI 0.75-1.05,p=0.15),无显著差异。
  • eGFR>45匹配亚组:透析率造影组2.0% vs 非造影组1.7%(OR 1.20,95%CI 0.66-2.17,p=0.55),无显著差异。
  • eGFR>45匹配亚组:死亡率造影组12% vs 非造影组14%(OR 0.87,95%CI 0.69-1.10,p=0.23),无显著差异。
  • eGFR≤45匹配亚组:透析率造影组6.7% vs 非造影组2.5%(OR 2.72,95%CI 1.14-6.46,p=0.0240),造影组显著更高。

证据类型、等级与局限

  • 证据类型:倾向评分校正的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对CT前eGFR>45的ICU患者,静脉碘造影剂未与AKI、急诊透析和短期死亡率风险增加相关。
  • 对CT前eGFR≤45的ICU患者,造影后透析风险增加(6.7% vs 2.5%,OR 2.72,95%CI 1.14-6.46)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To examine the association of intravenous iodinated contrast material administration with the subsequent development of post-contrast AKI (PC-AKI), emergent dialysis, and short-term mortality using a propensity score-adjusted analysis of a cohort of intensive care unit (ICU) patients who underwent CT examination.

METHODS: All ICU patients at our institution who received a contrast-enhanced (contrast group) or unenhanced (noncontrast group) CT scan from January 2006 to December 2014 were identified. Patients were subdivided into pre-CT eGFR > 45 and eGFR ≤ 45 subsets and separately underwent propensity score analysis. Rates of KDIGO-defined AKI, dialysis, and mortality were compared between contrast and noncontrast groups. Separate analyses of eGFR ≥ 60, 30-59, and <30 subsets were also performed.

RESULTS: A total of 6877 ICU patients (4351 contrast, 2526 noncontrast) were included in the study. Following propensity score adjustment, the rates of AKI (31 vs. 34%, OR .88 (95% CI .75-1.05), p = .15), dialysis (2.0 vs. 1.7%, OR 1.20 (.66-2.17), p = .55), and mortality (12 vs. 14%, OR .87 (.69-1.10), p = .23) were not significantly higher in the contrast versus noncontrast group in the matched eGFR > 45 subset. Significantly higher rates of dialysis (6.7 vs. 2.5%, OR 2.72 (1.14-6.46), p = .0240) were observed in the contrast versus noncontrast group in the matched eGFR ≤ 45 subset.

CONCLUSIONS: Intravenous contrast material administration was not associated with an increased risk of AKI, emergent dialysis, and short-term mortality in ICU patients with pre-CT eGFR > 45. An increased risk of dialysis was observed in patients with pre-CT eGFR ≤ 45.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. McDonald JS, McDonald RJ, Williamson EE, et al. Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med. 2017. PMID: 28213620. doi:10.1007/s00134-017-4699-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。